The abstract is read at the publisher; the summary is JClub's.
Syngap1 humanized-haploinsufficient mice (Syngap1 Hu/-) show epileptiform EEG activity and generalized slowing linked to disease-relevant behaviors, matching patient electrophysiology.
- Why it matters: Translating gene-targeted therapies is constrained by non-conserved genomic targets, so robust humanized models and shared biomarkers are needed to benchmark treatment effects.
- What they did: The team replaced entire Syngap1 or Stxbp1 loci with human counterparts, then assessed viability, behaviors, EEG signatures, and patient electrophysiology; they also tested human-specific antisense oligonucleotides in Syngap1 Hu/- neurons.
- The result: Patient cohorts with SYNGAP1-disorder exhibited similar electrophysiological signatures, and antisense oligonucleotides modulated human SYNGAP1 expression in Syngap1 Hu/- neurons, enabling translational biomarker benchmarking.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.